264 related articles for article (PubMed ID: 20133281)
21. Pulmonary light chain deposition disease: report of five cases and review of the literature.
Bhargava P; Rushin JM; Rusnock EJ; Hefter LG; Franks TJ; Sabnis SG; Travis WD
Am J Surg Pathol; 2007 Feb; 31(2):267-76. PubMed ID: 17255772
[TBL] [Abstract][Full Text] [Related]
22. Focal and segmental glomerulosclerosis and plasma cell proliferative disorders.
Dingli D; Larson DR; Plevak MF; Grande JP; Kyle RA
Am J Kidney Dis; 2005 Aug; 46(2):278-82. PubMed ID: 16112046
[TBL] [Abstract][Full Text] [Related]
23. Light chain crystal deposition as a manifestation of plasma cell dyscrasias: the role of immunoelectron microscopy.
Gu X; Barrios R; Cartwright J; Font RL; Truong L; Herrera GA
Hum Pathol; 2003 Mar; 34(3):270-7. PubMed ID: 12673562
[TBL] [Abstract][Full Text] [Related]
24. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.
Leung N; Dispenzieri A; Fervenza FC; Lacy MQ; Villicana R; Cavalcante JL; Gertz MA
Am J Kidney Dis; 2005 Aug; 46(2):270-7. PubMed ID: 16112045
[TBL] [Abstract][Full Text] [Related]
25. [Deposition of light chains in various organs; light chain deposition disease].
van Klaveren RJ; Holdrinet RS; Assmann KJ
Ned Tijdschr Geneeskd; 1989 May; 133(18):943-6. PubMed ID: 2498673
[TBL] [Abstract][Full Text] [Related]
26. Light chain deposition disease without detectable light chains in serum or urine. Report of a case and review of the literature.
van Ingen G; van Bronswijk H; Meijer CJ; Stel HV
Neth J Med; 1991 Oct; 39(3-4):142-7. PubMed ID: 1791875
[TBL] [Abstract][Full Text] [Related]
27. Can We Cure Light Chain Deposition Disease of the Kidneys?-A Review and Case Report of a Patient Treated With a Triple Transplant Approach.
Sivaraj D; Green MM; Ciftci AM; Zahid MF; Johns AA; Ross M; Gasparetto C
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e95-e100. PubMed ID: 27101986
[No Abstract] [Full Text] [Related]
28. A case of recurrent light chain deposition disease after living-related renal transplantation - detailed process of the recurrence.
Horike K; Takeda A; Otsuka Y; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
Clin Transplant; 2012 Jul; 26 Suppl 24():64-9. PubMed ID: 22747479
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of renal damage in plasma cell dyscrasias: an overview.
Merlini G; Pozzi C
Contrib Nephrol; 2007; 153():66-86. PubMed ID: 17075224
[TBL] [Abstract][Full Text] [Related]
30. [Serum free light-chain assay for nonsecretory multiple myeloma with light chain cast nephropathy and light chain deposition disease].
Honma R; Fukase S; Suzuki M; Omoto E
Rinsho Ketsueki; 2010 Apr; 51(4):270-4. PubMed ID: 20467224
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease.
Buxbaum J
Hematol Oncol Clin North Am; 1992 Apr; 6(2):323-46. PubMed ID: 1582976
[TBL] [Abstract][Full Text] [Related]
32. Morphologic heterogeneity of renal light-chain deposition disease.
Gokden N; Barlogie B; Liapis H
Ultrastruct Pathol; 2008; 32(1):17-24. PubMed ID: 18300034
[TBL] [Abstract][Full Text] [Related]
33. The biology of immunoglobulin free light chains and kidney injury.
Basnayake K; Stringer SJ; Hutchison CA; Cockwell P
Kidney Int; 2011 Jun; 79(12):1289-301. PubMed ID: 21490587
[TBL] [Abstract][Full Text] [Related]
34. Bortezomib-Based Chemotherapy with Autologous Stem Cell Transplantation for Monoclonal Gammopathy of Renal Significance: A Case Report and Literature Review.
Huang J; Sun C; Su H; Zhang C; Xiong J
Kidney Blood Press Res; 2019; 44(4):858-869. PubMed ID: 31352451
[TBL] [Abstract][Full Text] [Related]
35. Reversible left ventricular dysfunction and acute kidney injury in a patient with nonamyloid light chain deposition disease.
Wadhwa NK; Kamra A; Skopicki HA; Richard S; Miller F; Nord EP
Clin Nephrol; 2012 Dec; 78(6):501-5. PubMed ID: 23164419
[TBL] [Abstract][Full Text] [Related]
36. Sequential autologous peripheral blood stem cell transplantation and kidney transplantaion of light chain deposition disease.
Barraclough KA; Dowling JP; Schwarer AP; Perry GJ
Nephrol Dial Transplant; 2007 Apr; 22(4):1268-9. PubMed ID: 17110404
[No Abstract] [Full Text] [Related]
37. No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement.
Zeier M; Perz J; Linke RP; Donini U; Waldherr R; Andrassy K; Ho AD; Goldschmidt H
Nephrol Dial Transplant; 2003 Dec; 18(12):2644-7. PubMed ID: 14605290
[TBL] [Abstract][Full Text] [Related]
38. [Light chain deposition disease as a cause of renal failure].
Wohl P; Chadimová M; Englis M; Táborský P; Rossmann P; Matl I
Cas Lek Cesk; 1998 Nov; 137(23):721-4. PubMed ID: 9990176
[TBL] [Abstract][Full Text] [Related]
39. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.
Pozzi C; D'Amico M; Fogazzi GB; Curioni S; Ferrario F; Pasquali S; Quattrocchio G; Rollino C; Segagni S; Locatelli F
Am J Kidney Dis; 2003 Dec; 42(6):1154-63. PubMed ID: 14655186
[TBL] [Abstract][Full Text] [Related]
40. Histopathological atlas of renal diseases: light chain deposition disease.
Ferrario F; Rastaldi MP
J Nephrol; 2005; 18(5):499-502. PubMed ID: 16299674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
